Table 5.
Frequency and percentage of clinical complications among solid organ transplant recipients regarding different therapeutic regimens during the hospitalization period
| Medications | Complication | |||||
|---|---|---|---|---|---|---|
| Bacterial superinfection; n = 58 | Elevated liver enzymes; n = 123 | Reduced glomerular filtration rate; n = 31 | Neutropenia or thrombocytopenia; n = 29 | Cardiovascular; n = 67 | Gastrointestinal; n = 93 | |
| Hydroxychloroquine | 10 (17) | 32 (26) | 3 (10) | 2 (7) | 31 (46) | 49 (53) |
| Interferon | 11 (19) | 24 (20) | 2 (6) | 1 (3) | – | 1 (1) |
| Lopinavir/Ritonavir | 9 (16) | 41 (33) | 4 (13) | 2 (7) | 30 (45) | 22 (24) |
| Remdesivir | 7 (12) | 11 (9) | 12 (39) | 4 (14) | – | 9 (10) |
| Tocilizumab | 6 (10) | 8 (7) | 6 (19) | 13 (45) | 2 (3) | 7 (8) |
| Dexamethasone or High dose methylprednisolone | 15 (26) | 7 (6) | 4 (13) | 7 (24) | 4 (6) | 5 (5) |
| P value | 0.09 | 0.11 | 0.88 | 1.32 | 1.09 | 0.77 |